[DPHARMA] Director APPOINTMENT - DR BYUNG-GEON RHEE on 05-Oct-2015

Stock
[DPHARMA] : DUOPHARMA BIOTECH BERHAD
Announcement Date
05-Oct-2015
Board Member Information:
Date of Change
05-Oct-2015
Type of Change
APPOINTMENT
Designation
Director
Directorate
Independent and Non Executive
Name
DR BYUNG-GEON RHEE
Age
59
Nationality
Korea, Republic of
Qualification
1- Board Memberships and Affiliations
(i) Member, Advisory Board, Aquavit Pharmaceuticals Inc
(ii) Member, National Academy of Engineering Korea

2 - Education
(i) PhD, Chemical/Biomedical Engineering, Rice University
(ii) Bachelor of Science, Chemical Engineering, Seoul National University
(iii) Master of Science, Chemical Engineering, Seoul National University
Working Experience
Dr. B.G. Rhee brings 29 years of experience in research and management in biotechnology, as well as biopharmaceuticals. He is currently the President of Green Cross Holdings, a global leader in the healthcare industry that manufactures and sells medicine and medical supplies. Dr Rhee coordinates the overall business strategies of Green Cross' 16 affiliates comprised of a biotechnology industry companies located in South Korea, China, Canada as well as within the United States.

Previous to his current position, Dr. Rhee was President of Green Cross Corporation which specializes in the manufacture and sales of pharmaceuticals as well as medical devices and supplies. His prior positions include President & CEO at Expression Genetics, Inc., a clinical biopharmaceutical company in the United States; Head of Pharmaceutical Business at Samyang Corp.; and Head of Drug Development at LG Chem.
Directorship of Public Companies
Green Cross Holdings (Korea)
Family Relationship
None
Conflict of Interest
None
Interest
None
Market Buzz
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment